Cytokinetics Inc. buy Truist Financial Co.
Start price
03.02.26
/
50%
€56.50
Target price
03.02.27
€77.92
Performance (%)
-3.54%
Price
27.03.26
€54.50
Summary
This prediction is currently active. With a performance of -3.54%, the BUY prediction for Cytokinetics Inc. by Truist_Financial_Co_ is down slightly. This prediction currently runs until 03.02.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 1.869% | 1.869% |
| iShares Core DAX® | -1.742% | -10.677% |
| iShares Nasdaq 100 | -2.583% | -3.319% |
| iShares Nikkei 225® | -1.165% | -9.362% |
| iShares S&P 500 | -1.422% | -3.762% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at Truist Financial Corporation from $84.00 to $92.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€45.00
29.05.24
29.05.24
€64.57
29.05.25
29.05.25
-40.00%
30.05.25
30.05.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€68.00
08.04.24
08.04.24
€79.21
08.04.25
08.04.25
-53.24%
09.04.25
09.04.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€76.00
28.12.23
28.12.23
€77.64
28.12.24
28.12.24
-41.05%
29.12.24
29.12.24